Tropisetron enhances recognition memory in ovariectomized female rats

The present study evaluated the acute effects of the 5-HT3 receptor antagonist, tropisetron, on recognition memory in ovariectomized adult female rats. The non-spatial novel object recognition task was used to assess recognition memory. In this task, ovariectomized rats explored two identical objects during Trial 1. Immediately after Trial 1, rats were primed either with oil, 250 µg progesterone, 20 µg of estrogen, or 20 µg of estrogen + 250 µg progesterone. Four hours later, the test trial (Trial 2) was initiated. Thirty minutes before Trial 2, rats were injected intraperitoneally with either saline, 1.5 or 2.5 mg/Kg tropisetron. During Trial 2, one arm of the T maze contained an object from Trial 1 (familiar or previously encountered), and a new object (novel) was introduced into the other arm. Exploration times with the novel and familiar objects were recorded and data were converted to percent time spent with the novel object. In oil-primed ovariectomized female rats, treatment with 2.5 mg/Kg tropisetron significantly increased percent time with the novel object. Hormonal-priming with estrogen, progesterone, or estrogen + progesterone did not further accentuate the effects of tropisetron. These results suggest that although tropisetron, estrogen, and progesterone all act as antagonists at the 5-HT3 receptors and blocking 5-HT3 receptors enhances cognition, there appears to be no interaction between tropisetron and these hormones on object recognition.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:31

Enthalten in:

Behavioural pharmacology - 31(2020), 8 vom: 01. Dez., Seite 787-791

Sprache:

Englisch

Beteiligte Personen:

Hassell, Joel [VerfasserIn]
Maswood, Sharmin [VerfasserIn]

Links:

Volltext

Themen:

4G7DS2Q64Y
6I819NIK1W
Estrogens
Indoles
Journal Article
Progesterone
Receptors, Serotonin, 5-HT3
Research Support, Non-U.S. Gov't
Serotonin 5-HT3 Receptor Antagonists
Tropisetron

Anmerkungen:

Date Completed 07.09.2021

Date Revised 07.09.2021

published: Print

Citation Status MEDLINE

doi:

10.1097/FBP.0000000000000583

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM313897697